Skip to main content

Yen Kristen's Form 4 filing

Soleno Therapeutics Inc (SLNO) · filed Dec 14, 2023

Accession no.
0001209191-23-058705
Filed
Dec 14, 2023
Trade date
Dec 12-13, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.41M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Yen KristenCIK 0001643441Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 12, 2023Common StockSSaleDisposed−3,629$36.64−$132,966.5618,321Direct
Dec 12, 2023Common StockSSaleDisposed−16,284$37.02−$602,833.682,037Direct
Dec 13, 2023Common StockMOption exerciseAcquired+13,333$2.60+$34,665.815,370Direct
Dec 13, 2023Common StockMOption exerciseAcquired+4,583$2.41+$11,045.0319,953Direct
Dec 13, 2023Common StockSSaleDisposed−17,916$37.76−$676,508.162,037Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 13, 2023Common StockMOption exerciseDisposed−13,333$0.00$00Direct
Dec 13, 2023Common StockMOption exerciseDisposed−4,583$0.00$015,417Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)